首页 › 基金 › Nicholas Investment Partners, LP › BBIO

Nicholas Investment Partners, LP 对 BBIO 的持仓历史

BRIDGEBIO PHARMA INC · 医疗保健

Nicholas Investment Partners, LP 在 Q3 2026 的 13F 申报中披露持有 BBIO(BRIDGEBIO PHARMA INC)6,000,000 股,市值约 US$9.0M,约占其申报组合的 0.68%,在其申报持仓中市值排名第 48 位。 Nicholas Investment Partners, LP 最近 9 个申报季度中有 9 个季度披露了 BBIO 持仓,最早可追溯至 Q3 2024。

最新持仓 (Q3 2026)6.00M 股
申报持仓市值$9.04M
组合权重0.68%
首次申报Q3 2024
最近变动持有
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

Nicholas Investment Partners, LP 对 BBIO 的持仓演变

Nicholas Investment Partners, LP 于 Q3 2024 首次披露 BBIO 持仓:35,644 股(约 US$907K)。 该持仓在 Q4 2025 达到峰值 284,682 股,市值约 US$21.8M。 在 9 次申报中,Nicholas Investment Partners, LP 5 次增持、1 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 6,000,000 股、市值约 US$9.0M。 持仓曾出现大幅变动:Q1 2025 增持约 178% (随后一个季度股价上涨 25%)、Q3 2025 增持约 70% (随后一个季度股价上涨 47%)、Q1 2026 增持约 2008% (随后一个季度股价基本持平)。

逐季持仓明细

季度股数金额变化
Q3 2024 35.64K $907.50K 新进
Q4 2024 59.89K $1.64M 增持
Q1 2025 166.66K $5.76M 增持
Q2 2025 159.50K $6.89M 减持
Q3 2025 271.63K $14.11M 增持
Q4 2025 284.68K $21.78M 增持
Q1 2026 6.00M $10.17M 增持
Q2 2026 6.00M $10.09M 持有
Q3 2026 6.00M $9.04M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 BBIO 与 13F 数据

BBIO(BRIDGEBIO PHARMA INC)属于医疗保健行业。我们追踪的基金中还有 42 只申报持有 BBIO,申报仓位最大的包括:Jupiter Topco LLC (US$1.05B), 骏利亨德森集团 (US$978.6M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$937.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 BBIO 的基金

查看 BBIO 的全部基金持有人 →

常见问题

How long has Nicholas Investment Partners, LP held BBIO?

Nicholas Investment Partners, LP has disclosed BBIO holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Nicholas Investment Partners, LP's current position in BBIO?

As of Q3 2026, Nicholas Investment Partners, LP holds 6.00M shares of BBIO (BRIDGEBIO PHARMA INC), valued at $9.04M, representing 0.68% of its reported portfolio and ranking #48.

Has Nicholas Investment Partners, LP been buying or selling BBIO?

In the latest 13F filing (Q3 2026), Nicholas Investment Partners, LP held unchanged its position in BBIO. The position peaked in Q4 2025 at 284.68K shares.

Which other funds hold BBIO?

Other major institutional holders of BBIO include Jupiter Topco LLC, 骏利亨德森集团, FARALLON CAPITAL MANAGEMENT, L.L.C., among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.